Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ninjinyoeito for nontuberculous mycobacterial pulmonary disease with weight loss and anorexia
jRCTs031220576Recruiting
- Sponsor
- Kracie
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ninjinyoeito in nontuberculous mycobacterial lung disease and anorexia nervosa (AN) (2 arms), sponsored by Kracie. Primary endpoint: Change in body weight from baseline to 24 weeks. Started Aug 2023; status: recruiting.
02
Drugs
ninjinyoeito
03
Conditions
nontuberculous mycobacterial lung diseaseanorexia nervosa (AN)
Beyond the preview
Go deeper on jRCTs031220576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220576.